Evidence map›Paper›PMID 34736970›Full record

ArticleJournal of hepatology2022

Reply to: "An EASL position paper for systemic treatment of hepatocellular carcinoma: Go forward courageously".

Bruno Sangro, Jordi Bruix, Stephen L Chan, Peter R Galle, Lorenza Rimassa

Open access · bronzeAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in Journal of hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 4 countries.

Bruno SangroLiver Unit and HPB Oncology Area, Clinica Universidad de Navarra-IDISNA and CIBEREHD, Pamplona, Spain. Electronic address: bsangro@unav.es.
Jordi BruixBCLC Group, Liver Unit, Hospital Clínic, University of Barcelona, IDIBAPS, CIBEREHD, Barcelona, Spain.
Stephen L ChanDepartment of Clinical Oncology, State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, China.
Peter R GalleUniversity Medical Center Mainz, Mainz, Germany.
Lorenza RimassaDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy; Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy.
Centro de Investigación Biomédica en Red · ESHumanitas University · ITPrince of Wales Hospital · CNUniversitat de Barcelona · ESUniversity Medical Center of the Johannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsConsensus Statements as TopicHumansTreatment Outcome

Identifiers

PMID34736970
OpenAlexW3208608301

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.